Evolent Health (NYSE: EVH) reported Q4 EPS of ($0.33), $0.13 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $88 million versus the consensus estimate of $84.98 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.